Perrigo Receives FDA Approval For Opill OTC Contraceptive Pill
Portfolio Pulse from Benzinga Newsdesk
Perrigo Company plc (PRGO) has received FDA approval for its over-the-counter contraceptive pill, Opill. This approval could potentially boost the company's revenues and market share in the pharmaceutical industry.
July 13, 2023 | 12:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Perrigo's FDA approval for Opill could potentially increase its revenues and market share. This positive news may lead to a short-term increase in the company's stock price.
FDA approval for a new product like Opill is a significant milestone for Perrigo. It opens up a new revenue stream and enhances the company's product portfolio. This positive news is likely to be well received by the market, potentially leading to a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100